ICCC 8-K 2026-01-08

IMMUCELL CORP /DE/ (ICCC) 8-K dated 2026-01-08 — accession 0001437749-26-000885. This URL is the filing, not the ICCC hub.

IMMUCELL CORP /DE/ (ICCC) is a biotechnology company listed on US.

IMMUCELL CORP /DE/ filed a 8-K on 2026-01-08. Accession 0001437749-26-000885.

Cached items: 2.02, 2.06, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.

Not investment advice. The ICCC SEC hub lists recent forms. The stock page is the research view.